Ocular manifestations of inflammatory bowel disease

Akshay S. Thomas, Phoebe Lin

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Purpose of review Extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) are numerous and can often involve the eye. This review highlights the ocular complications associated with IBD including the critical role the ophthalmologist can play in the diagnosis of IBD, the pathogenesis of IBD, its ocular complications, and the treatment of ocular inflammation associated with IBD. Recent findings Polygenic and environmental influences, as well as gut microbial dysbiosis, have been implicated in the pathogenesis of IBD. IBD and its EIMs appear to respond well to TNFa-Targeted biologics. Summary IBD is thought to be caused by polygenic and environmental influences, including a dysbiotic gut microbiota. It is a systemic immune-mediated disease with varying types of ocular manifestations that can precede, occur simultaneously, or follow intestinal involvement. The diagnosis of IBD can be confused with other seronegative spondyloarthropathies as well as Behçet's disease. Treatment of IBD-Associated ocular inflammation can range from corticosteroids to steroid-sparing immunosuppression such as azathioprine or methotrexate. Refractory disease can respond well to TNFa inhibitors.

Original languageEnglish (US)
Pages (from-to)552-560
Number of pages9
JournalCurrent Opinion in Ophthalmology
Volume27
Issue number6
DOIs
StatePublished - Nov 1 2016

Fingerprint

Eye Manifestations
Inflammatory Bowel Diseases
Dysbiosis
Inflammation
Spondylarthropathies
Immune System Diseases
Azathioprine
Biological Products
Methotrexate
Immunosuppression
Adrenal Cortex Hormones

Keywords

  • Gut Microbiome
  • Inflammatory Bowel Disease
  • Ocular Inflammation

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Ocular manifestations of inflammatory bowel disease. / Thomas, Akshay S.; Lin, Phoebe.

In: Current Opinion in Ophthalmology, Vol. 27, No. 6, 01.11.2016, p. 552-560.

Research output: Contribution to journalReview article

@article{e6fcf15213c14c83ae537aa2dedf6f41,
title = "Ocular manifestations of inflammatory bowel disease",
abstract = "Purpose of review Extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) are numerous and can often involve the eye. This review highlights the ocular complications associated with IBD including the critical role the ophthalmologist can play in the diagnosis of IBD, the pathogenesis of IBD, its ocular complications, and the treatment of ocular inflammation associated with IBD. Recent findings Polygenic and environmental influences, as well as gut microbial dysbiosis, have been implicated in the pathogenesis of IBD. IBD and its EIMs appear to respond well to TNFa-Targeted biologics. Summary IBD is thought to be caused by polygenic and environmental influences, including a dysbiotic gut microbiota. It is a systemic immune-mediated disease with varying types of ocular manifestations that can precede, occur simultaneously, or follow intestinal involvement. The diagnosis of IBD can be confused with other seronegative spondyloarthropathies as well as Beh{\cc}et's disease. Treatment of IBD-Associated ocular inflammation can range from corticosteroids to steroid-sparing immunosuppression such as azathioprine or methotrexate. Refractory disease can respond well to TNFa inhibitors.",
keywords = "Gut Microbiome, Inflammatory Bowel Disease, Ocular Inflammation",
author = "Thomas, {Akshay S.} and Phoebe Lin",
year = "2016",
month = "11",
day = "1",
doi = "10.1097/ICU.0000000000000310",
language = "English (US)",
volume = "27",
pages = "552--560",
journal = "Current Opinion in Ophthalmology",
issn = "1040-8738",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Ocular manifestations of inflammatory bowel disease

AU - Thomas, Akshay S.

AU - Lin, Phoebe

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Purpose of review Extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) are numerous and can often involve the eye. This review highlights the ocular complications associated with IBD including the critical role the ophthalmologist can play in the diagnosis of IBD, the pathogenesis of IBD, its ocular complications, and the treatment of ocular inflammation associated with IBD. Recent findings Polygenic and environmental influences, as well as gut microbial dysbiosis, have been implicated in the pathogenesis of IBD. IBD and its EIMs appear to respond well to TNFa-Targeted biologics. Summary IBD is thought to be caused by polygenic and environmental influences, including a dysbiotic gut microbiota. It is a systemic immune-mediated disease with varying types of ocular manifestations that can precede, occur simultaneously, or follow intestinal involvement. The diagnosis of IBD can be confused with other seronegative spondyloarthropathies as well as Behçet's disease. Treatment of IBD-Associated ocular inflammation can range from corticosteroids to steroid-sparing immunosuppression such as azathioprine or methotrexate. Refractory disease can respond well to TNFa inhibitors.

AB - Purpose of review Extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) are numerous and can often involve the eye. This review highlights the ocular complications associated with IBD including the critical role the ophthalmologist can play in the diagnosis of IBD, the pathogenesis of IBD, its ocular complications, and the treatment of ocular inflammation associated with IBD. Recent findings Polygenic and environmental influences, as well as gut microbial dysbiosis, have been implicated in the pathogenesis of IBD. IBD and its EIMs appear to respond well to TNFa-Targeted biologics. Summary IBD is thought to be caused by polygenic and environmental influences, including a dysbiotic gut microbiota. It is a systemic immune-mediated disease with varying types of ocular manifestations that can precede, occur simultaneously, or follow intestinal involvement. The diagnosis of IBD can be confused with other seronegative spondyloarthropathies as well as Behçet's disease. Treatment of IBD-Associated ocular inflammation can range from corticosteroids to steroid-sparing immunosuppression such as azathioprine or methotrexate. Refractory disease can respond well to TNFa inhibitors.

KW - Gut Microbiome

KW - Inflammatory Bowel Disease

KW - Ocular Inflammation

UR - http://www.scopus.com/inward/record.url?scp=84984680159&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984680159&partnerID=8YFLogxK

U2 - 10.1097/ICU.0000000000000310

DO - 10.1097/ICU.0000000000000310

M3 - Review article

VL - 27

SP - 552

EP - 560

JO - Current Opinion in Ophthalmology

JF - Current Opinion in Ophthalmology

SN - 1040-8738

IS - 6

ER -